TP53 and melanoma: Contrariwise, the defects in the superjacent mechanisms of p53activation in response to DNA damage (e.g., mutations in Chk2/hCds1 disablingSer376 phosphorylation of p53 upon irradiation) are associated with thedevelopment of radioresistance by melanoma cells.